| Literature DB >> 24148097 |
Naseer Ali Shah, Muhammad Rashid Khan1, Bushra Ahmad, Farah Noureen, Umbreen Rashid, Rahmat Ali Khan.
Abstract
BACKGROUND: Sida cordata, a member of Family Malvaceae is used in folk medicine for various ailments including liver diseases. In this study we investigated, its flavonoid constituents, in vitro antioxidant potential against different free radicals and hepatoprotection against carbon tetrachloride (CCl4)-induced liver damage in rat.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24148097 PMCID: PMC3874743 DOI: 10.1186/1472-6882-13-276
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Flow sheet of extraction and fractionation of with percent yield.
Quantitative profile of total flavonoids content and total phenolic content in the methanol extract and various fractions of
| SCME | 154±6.7a | 286.7±17.5c |
| SCHE | 66±5.1e | 49.0±3.6d |
| SCEE | 312±1b | 683.3±15.3a |
| SCBE | 246±1c | 485.3±13.2b |
| SCAE | 88±5.6d | 24.6±2.7e |
Each values represented in tables are means ± SD (N=3). Values with different superscripts within same column are significantly different (P<0.05). (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.
IC values of different antioxidant assays of extract and various fractions of
| DPPH scavenging activity | 235±1.4c | 795±5.3a | 135±1.2e | 147±1.4d | 275±3.2b | 25±1.1f |
| Hydrogen peroxide scavenging activity | 272±1.8c | 469±2.7b | 154±2.3e | 223±2.1d | 622±3.7a | 99±2.2f |
| Hydroxyl radical scavenging activity | 298±2.1c | 578±4.2a | 189±1.5d | 206±1.3e | 455±4.1b | 32±0.9f |
| ABTS scavenging activity | 259±0.9a | 260±2.1a | 143±0.8d | 224±1.4c | 236±2.2b | 55±1.3e |
| Anti lipid per oxidation activity | 212±3.1c | 276±2.6b | 119±1.0e | 153±1.1d | 314±2.8a | 31±0.8f |
| β -carotene bleaching activity | 221±1.7c | 647±3.9a | 153±1.1d | 156±1.7d | 249±1.6b | 35±1.7e |
| Superoxide radical scavenging activity | 139±2.0c | 197±2.3b | 114±1.3d | 136±2.1c | 242±3.1a | 41±2.3e |
Values are expressed as mean±SD (N=3), a=Ascorbic acid. Means with superscripts with different letters in the rows are significantly (P<0.05) different from each other. (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.
IC correlation with total flavonoid and total phenolic contents
| DPPH scavenging activity | 0.57 | 0.46 |
| Hydrogen peroxide scavenging activity | 0.78* | 0.86* |
| Hydroxyl radical scavenging activity | 0.89** | 0.85* |
| ABTS scavenging activity | 0.67* | 0.65 |
| Anti lipid per oxidation activity | 0.92** | 0.97** |
| β - carotene bleaching scavenging activity | 0.55 | 0.44 |
| Superoxide radical scavenging activity | 0.73* | 0.82* |
Values are expressed as mean±SD (N=3). Values within the same column with different superscripts letter are significantly different. *=P<0.05; **=P<0.01.
Effect of SCEE treatment on different liver markers
| Control | 1847±21.2e | 0.33±0.1b | 22.67±1.5b | 38.7±3.5d | 56.0±1.0cd | 0.937±0.0de |
| Oil+DMSO | 1964±30.2cd | 0.33±0.1b | 21±1.00bc | 40.3±1.5cd | 54.0±1.0d | 0.863±0.0e |
| CCl4 (1 ml/kg) | 3268±55.7a | 0.90±1.0a | 43.3±1.5a | 70.0±3.0a | 91.3±2.5a | 2.58±0.21a |
| Silymarin (200 mg/kg)+CCl4 | 1753±15.3f | 0.37±0.1b | 18.0±1.0a | 44.7±2.5cd | 60.3±2.5c | 1.16±0.10cd |
| SCEE (150 mg/kg)+CCl4 | 2207±21.4b | 0.43±0.1b | 20.0±1.0bc | 56.3±3.1b | 71.3±1.5b | 1.77±0.20b |
| SCEE (300 mg/kg)+CCl4 | 2054±48.0c | 0.43±0.1b | 20.5±0.5bc | 47.0±2.6c | 69.0±1.0b | 1.35±0.17c |
| SCEE (300 mg/kg) | 1902±20.4d | 0.33±0.1b | 22.0±1.0b | 40.7±2.5cd | 58.7±1.5cd | 1.04±0.10de |
Values are expressed as mean±SD (N=3). Values within the same column with different superscripts letters are significantly (P<0.05) different. (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.
Effects of SCEE treatment on antioxidant enzymes profile of liver
| Control | 6.1±0.2ab | 10.1±0.2a | 4.1±0.2a | 129±9.5a | 81.1±4.8a | 131.3±8.5ab |
| Oil+DMSO | 5.7±0.2bc | 9.9±0.2a | 3.9±0.1a | 113±6.0bc | 73.7±8.0ab | 121.3±8.5ab |
| CCl4 (1 ml/kg) | 1.8±0.1e | 4.3±0.2b | 1.2±0.2d | 56±8.0e | 47.0±9.2c | 65.7±6.1d |
| Silymarin (200 mg/kg)+CCl4 | 5.4±0.1c | 8.4±0.3b | 3.2±0.1b | 107±8.0bc | 73.3±5.5ab | 111±6.0bc |
| SCEE (150 mg/kg)+CCl4 | 3.9±0.2d | 6.6±0.4c | 2.3±0.2c | 82.7±5.5d | 60.3±3.1bc | 94.3±6.1c |
| SCEE (300 mg/kg)+CCl4 | 4.4±0.3d | 7.3±0.5c | 2.6±0.2c | 101±6.0cd | 65.7±2.9ab | 111±5.3bc |
| SCEE (300 mg/kg) | 6.3±0.2a | 10.2±0.3a | 4.1±0.1a | 123±9.7ab | 71.7±3.5ab | 135.7±11.4a |
Values are expressed as mean±SD (N=3). Values within the same column with different superscripts letters are significantly (P<0.05) different. (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.
Effects of SCEE administration on protein, TBARS and GSH profile of liver
| Control | 3.1±0.1a | 1.3±0.2d | 29.3±2.5a |
| Oil+DMSO | 2.6±0.2b | 1.4±0.2d | 25.7±2.1a |
| CCl4 (1 ml/kg) | 1.3±0.2d | 3.7±0.4a | 11.3±2.5c |
| Silymarin (200 mg/kg)+CCl4 | 2.8±0.2ab | 1.8±0.2cd | 27.3±3.5a |
| SCEE (150 mg/kg)+CCl4 | 1.5±0.1cd | 2.7±0.1b | 17.7±3.1bc |
| SCEE (300 mg/kg)+CCl4 | 1.8±0.1c | 2.3±0.2bc | 24.0±2.7ab |
| SCEE (300 mg/kg) | 2.8±0.1ab | 1.6±0.2cd | 31.0±2.7a |
Values are expressed as mean±SD (N=3). Values within the same column with different superscripts letters are significantly (P<0.05) different. (SCHE); n-hexane fraction, (SCEE); ethyl acetate fraction, (SCBE); n-butanol fraction, (SCAE), aqueous fraction.
Figure 2Rat liver microscopic photograph (H & E stain).2a; Represents normal liver section, 2b; Vehicle control, 2c; CCl4 treated control, 2d; CCl4+silymerin treated, 2e; CCl4 +SCEE 150 mg/kg treated, 2f; CCl4+SCEE 300 mg/kg treated 2g; only SCEE 300 mg/kg treated. CV (Central vein), S (Sinusoids) and HPC (Hepatocytes). DLS (Degeneration of lobular shape), FC (Fatty change), and D& C (Dilation and congestion of central vein).